Ralph Lauren and Haemonetics Raise FY2027 Revenue Growth Outlooks

Ralph Lauren has increased its FY2027 revenue growth outlook to 5%-6% with operating margin expansion, while Haemonetics forecasts 5% to 8% FY 2027 reported revenue growth, raising guidance due to strong Q1 performance.